Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
6.17
+0.71 (13.00%)
Nov 5, 2024, 3:46 PM EST - Market open
Orchestra BioMed Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 233 | 326 | 112 | 206 | 262 |
| Market Cap Growth | 16.54% | 191.65% | -45.72% | -21.31% | - |
| Enterprise Value | 143 | 229 | 193 | - | - |
| Last Close Price | 5.46 | 9.13 | 9.98 | 10.08 | 12.81 |
| PE Ratio | - | -6.18 | -4.45 | -0.92 | -1.21 |
| PS Ratio | 93.25 | 118.24 | 31.67 | -263.60 | 45.93 |
| PB Ratio | 4.43 | 4.80 | 2.13 | -10.42 | 90.02 |
| P/FCF Ratio | -6.52 | -7.06 | -3.74 | -10.46 | -9.80 |
| P/OCF Ratio | -6.54 | -7.07 | -3.82 | -10.61 | -10.01 |
| EV/Sales Ratio | 68.68 | 82.95 | 54.51 | - | - |
| EV/EBITDA Ratio | -3.76 | -4.47 | -5.94 | - | - |
| EV/EBIT Ratio | -3.74 | -4.45 | -5.90 | - | - |
| EV/FCF Ratio | -4.88 | -4.96 | -6.44 | - | - |
| Debt / Equity Ratio | 0.03 | 0.02 | 0.23 | -0.29 | 3.25 |
| Debt / FCF Ratio | -0.03 | -0.04 | -0.40 | -0.29 | -0.35 |
| Asset Turnover | 0.02 | 0.03 | 0.06 | - | - |
| Inventory Turnover | 1.34 | 0.88 | 1.23 | 2.91 | - |
| Quick Ratio | 4.50 | 7.82 | 4.52 | 0.90 | 2.50 |
| Current Ratio | 4.58 | 7.95 | 4.56 | 0.92 | 2.52 |
| Return on Equity (ROE) | -83.22% | -81.47% | -205.21% | - | - |
| Return on Assets (ROA) | -36.75% | -33.75% | -37.42% | -52.79% | - |
| Return on Capital (ROIC) | -49.69% | -48.00% | -81.16% | - | - |
| Earnings Yield | -26.91% | -15.05% | -30.03% | -11.16% | -8.15% |
| FCF Yield | -21.65% | -14.16% | -26.70% | -9.56% | -10.20% |
| Buyback Yield / Dilution | -66.07% | -121.67% | -609.97% | -4.86% | - |
| Total Shareholder Return | -66.07% | -121.67% | -609.97% | -4.86% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.